Arcxis Receives Investment from IQT for Sample Prep, Molecular Dx Development

The investment expands Arxcis' ongoing collaboration with IQT to develop Arcxis' fully automated RNA and DNA sample-preparation device, expected to launch later this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.